Senators Wyden and Merkley Push FDA on Hemp‑Derived CBD Regulation Amid State‑Level Conflicts
Senators Wyden and Merkley Push FDA on Hemp‑Derived CBD Regulation Amid State‑Level Conflicts The passage highlights a congressional inquiry (letters from two senators) requesting FDA guidance on hemp‑derived cannabinoids, referencing specific FDA warning letters and state actions. It offers concrete leads—names, dates, and documents—to follow up on regulatory enforcement and potential industry pushback, but the information is largely public and already reported, limiting its novelty and impact. Key insights: Senators Ron Wyden and Jeff Merkley sent a letter to the FDA on Jan. 15, 2019 requesting clarification on hemp‑derived CBD/THC in food and supplements.; The senators authored the 2018 Farm Bill’s Hemp Farming Act provision, indicating legislative intent for broader hemp product access.; FDA warning letters on CBD products are publicly listed (links provided).
Summary
Senators Wyden and Merkley Push FDA on Hemp‑Derived CBD Regulation Amid State‑Level Conflicts The passage highlights a congressional inquiry (letters from two senators) requesting FDA guidance on hemp‑derived cannabinoids, referencing specific FDA warning letters and state actions. It offers concrete leads—names, dates, and documents—to follow up on regulatory enforcement and potential industry pushback, but the information is largely public and already reported, limiting its novelty and impact. Key insights: Senators Ron Wyden and Jeff Merkley sent a letter to the FDA on Jan. 15, 2019 requesting clarification on hemp‑derived CBD/THC in food and supplements.; The senators authored the 2018 Farm Bill’s Hemp Farming Act provision, indicating legislative intent for broader hemp product access.; FDA warning letters on CBD products are publicly listed (links provided).
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.